A trial looking at datopotamab deruxtecan for non small cell lung cancer (TROPION-Lung17)

This trial is looking at datopotamab deruxtecan for previously treated locally advanced or advanced non small cell lung cancer.

It is open for people who have non small cell lung cancer that has spread:

• into the nearby tissue or lymph nodes (locally advanced) or

• to another part of the body (advanced)

You pronounce datopotamab deruxtecan as day-toe-pot-oh-mab deh-rux-tee-can. It is also called Dato-DXd for short.